Religare Enterprises Limited – Investor Presentation Summary

Key Operational Highlights

  • Care Health Insurance Limited reported Gross Written Premium (GWP) of ₹6,400 crore in H1 FY27, representing 40.6% YoY growth
  • Religare Broking Limited serves approximately 2.3 lakh active customers with a strong digital ecosystem including Dynami, Religare Online, and LEAP platforms
  • Religare Finvest Limited resumed lending operations on November 6, 2026, offering loan against property, business loans, and used car loans
  • Religare Broking Limited showed 51% YoY growth in client debit book and maintains a strong E-Gov Franchisee of 64k

Segment-wise Performance

Insurance Segment (Primarily Care Health Insurance):

  • Q2 FY27 Revenue: ₹2,240.94 crore
  • H1 FY27 Revenue: ₹4,439.02 crore
  • Q2 FY27 Segment Performance: Loss of ₹158.19 crore
  • H1 FY27 Segment Performance: Loss of ₹245.45 crore

Financial Services Segment:

  • Q2 FY27 Revenue: ₹154.28 crore
  • H1 FY27 Revenue: ₹287.41 crore
  • Q2 FY27 Segment Performance: Profit of ₹37.29 crore
  • H1 FY27 Segment Performance: Profit of ₹50.56 crore

Financial Highlights

Consolidated Performance (REL):

  • H1 FY27 Total Income: ₹4,716.52 crore
  • H1 FY27 Net Loss: ₹144.67 crore
  • Q2 FY27 Total Income: ₹2,389.75 crore
  • Q2 FY27 Net Loss: ₹97.69 crore
  • Finance Costs: ₹36.09 crore (H1 FY27), ₹21.08 crore (Q2 FY27)
  • Employee Benefit Expenses: ₹662.06 crore (H1 FY27), ₹337.59 crore (Q2 FY27)

Standalone Performance (REL):

  • H1 FY27 Total Income: ₹7.57 crore
  • H1 FY27 Net Loss: ₹23.05 crore
  • Q2 FY27 Total Income: ₹3.18 crore
  • Q2 FY27 Net Loss: ₹13.45 crore

Religare Broking Limited Financials

  • H1 FY27 Total Income: ₹197.1 crore (7% YoY growth)
  • H1 FY27 PBT: ₹13.0 crore (29% YoY growth)
  • H1 FY27 PAT: ₹9.7 crore
  • Q2 FY27 Brokerage: ₹44.7 crore
  • Q2 FY27 Interest Income: ₹32.5 crore (22% YoY growth)
  • Raised ₹100 crore through Rights Issue from Parent Company in August 2026
  • CRISIL Ratings upgrade: Long-Term to CRISIL BBB+/Stable, Short-Term to CRISIL A2+

Religare Finvest Limited Financials

  • Tangible Net Worth: ₹962.6 crore (as of September 30, 2026)
  • Cash and Liquid Investments: ₹660.0 crore
  • Capital Adequacy (CRAR): 231.8%
  • H1 FY27 Net Total Income: ₹58.7 crore
  • H1 FY27 Profit After Tax: ₹64.5 crore
  • Q2 FY27 Interest Income: ₹39.3 crore

Religare Housing Development Finance Corporation Limited Financials

  • H1 FY27 Total Income: ₹14.39 crore
  • H1 FY27 Loss After Tax: ₹13.35 crore
  • Q2 FY27 Interest Income: ₹7.44 crore
  • Portfolio LTV: 54% (for cases outstanding as of Q2 FY27)

Care Health Insurance Limited Performance

H1 FY27 Key Metrics:

  • Gross Written Premium (GWP): ₹6,400 crore (40.6% YoY growth)
  • Retail Health GWP: ₹4,049 crore (50.7% YoY growth)
  • Claims Ratio: 66.1%
  • Expense Ratio: 34.4%
  • Combined Insurance Service Ratio: 100.5%
  • Return on average equity (PBT): 12.1%
  • Assets Under Management: ₹12,897 crore
  • Solvency Ratio: 1.55
  • Yield on Investment (Annualized): 7.1%

Investment Portfolio:

  • 95% of debt portfolio rated AAA/Government Securities
  • AUM registered CAGR >30% over past 5 years

Balance Sheet Snapshot (Consolidated)

  • Total Assets: ₹16,267.50 crore
  • Total Liabilities: ₹12,331.70 crore
  • Insurance Segment Assets: ₹13,781.99 crore
  • Insurance Segment Liabilities: ₹11,278.51 crore
  • Financial Services Segment Assets: ₹2,456.14 crore
  • Financial Services Segment Liabilities: ₹948.94 crore

Strategic & Digital Initiatives

Care Health Insurance Digital Transformation:

  • Building seamless, digital-first healthcare experience
  • Customer app: "One App. Whole Health" providing comprehensive health management

Religare Finvest Restart Strategy:

  • Secured-first retail lending approach with collateral-backed, granular portfolio
  • Tech-led underwriting with branch-led relationships
  • Opened three branches in three days, disbursed first loan on day four of operations

Management & Board Overview

Board of Directors:

  • Dr. Anand Chand Burman - Non-Executive and Non-Independent Director, Chairman Emeritus of Dabur India
  • Mr. Mohit Burman - Independent Director, Chairman of Dabur India
  • Mr. Aditya Chand Burman - Non-Executive and Non-Independent Director
  • Mr. Jimeet Vipul Modi - Non-Executive and Non-Independent Director, Founder and Group CEO of SAMCO Group

Company Tag